/CNW/ - PanGenomic Health Inc. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. +0,0001 EUR. Announces that further to its news release of September 1, 2022, it has entered into a definitive share. marktüblicher Spreads)! Oskar ist der einfache und intelligente ETF-Sparplan. 9, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital marketing services (the "Services"). PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. is a public benefit company. Name. colleagues at the BC Patient Safety & Quality Council, are thrilled to mark our 11th annual Quality Forum by hosting participants in person once again. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. Anzeige. The detail page will show you the real-time trend, you can click into the MSN Money website for more detailsBörsenkurse: Meistgesuchte Aktien. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Fobi AI (FOBI) announced the commercial launch of its wholly-owned subsidiary, PulseIR, with the signing of its first customer, PanGenomic Health Inc. PanGenomic Health Inc. CN stock on Yahoo Finance. The Health Professions Review Board (HPRB) is an administrative tribunal created under the Health Professions Act (the Act). Kurs Meyer Burger Technology 0,2594 EUR22 Apr 2023, 07:10. All values updated annually at fiscal year end. PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture. com info@pangenomic. (LL30. announced that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. com folgen. info@pangenomic. 38m; Incorporated 2015; Employees--Location Pangenomic Health Inc 102 3800 Wesbrook Mall VANCOUVER V6S 2L9 Canada CAN;. The two companies are jointly developing targeted biomarker diagnostics to help patients undergoing. VANCOUVER, BC, Nov. (OTCPK:MYCO. 011 expected by the market. Earnings vs Industry: NARA is unprofitable, making it difficult to compare its past year. PANGENOMIC HEALTH A AKTIE und aktueller Aktienkurs. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 Aug. 616M. Im Jahr 2022 hat Pangenomic Health Inc 0,00€ ausgeschüttet. Jetzt im Neujahr sehe ich, dass dieser Verlust nicht mehr da ist. Latest Pangenomic Health Inc (LL30:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and. 2021 habe ich mit Aktien Verlust gemacht (ca. S&P 500. Seite 1 der Diskussion 'Wird PanGenomic Health der neue Star am Mobile Medical. *Close price adjusted for splits. kündigt Rücktritt von Direktoren an 13. Under the terms of the agreement, Bello will provide. Pangenomic Health Inc. NARA Date: December 23, 2022 Is this an updating or amending Notice: Yes No If yes provide date(s) of prior Notices: Issued and Outstanding Securities of Issuer Prior to Issuance: 93,040,972 Pricing Date of news release announcing proposed issuance: N/A orPanGenomic Health Aktie, WKN: A3DN26, ISIN: CA69842E2050 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen In Ihrem Browser ist JavaScript deaktiviert. 00; Net income in CAD-12. The company was founded by Robert Nygren and Vincent Lum on December 11, 2015 and is headquartered in Vancouver, Canada. PANGENOMIC HEALTH A Aktie Orderbuch Xetra - Bid-Ask Volumen mit aktuellen Kursen - Times & Sales zu A3DN26 - CA69842E2050 - Realtimekurse VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. Apr. MUJN Diagnostics Inc. F) stock quote, history, news and other vital information to help you with your stock trading and investing. Log in to view data. Linked companies : Mydecine Innovations Group Inc. Cookies are used to offer you a better browsing experience and to analyze our traffic. company and executive profile by Barron's. PanGenomic Health Inc. PANGENOMIC HEALTH A Fundamentalanalyse - hier erhalten Sie eine Analyse der PANGENOMIC HEALTH A Aktie nach fundamentalen Kennzahlen wie KGV, relative Performance, Mittelfrist-Trend usw. com. 62%. DAX Liste Realtime Indikation. Anzeige. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it plans to launch its e-commerce platform for personalized natural health solutions this month. PANGENOMIC HEALTH A Chart - ein übersichtlicher, großer Chart der PANGENOMIC HEALTH A Aktie. . Information on stock, financials, earnings, subsidiaries, investors, and. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to provide an update on its NARA product and announce that it. com. Top Smart Score Stocks. Nachrichten zur Aktie BMW AG | 519000 | BAMXF | DE0005190003. Newswire. 778 743 4642 [email protected], BC, Aug. Key statistics. The Company's initial. PANGENOMIC HEALTH A Rating: Hier finden Sie Rating-Informationen zu PANGENOMIC HEALTH A und Ratings der PANGENOMIC HEALTH A Anleihen sowie. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI. 778 743 4642. Analyst. PanGenomic Health Inc. NARA | Complete PanGenomic Health Inc. ir@pangenomic. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. 12, 2023 /CNW/ - PanGenomic Health Inc. ca). NARA | Complete PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Kurs. operates as a precision health company. 23, 2022 /CNW/ - PanGenomic Health Inc. Find the latest Pangenomic Health Inc. Fobi AI Inc. VANCOUVER, BC, Nov. 000 Aktien. Jan 23, 2023. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. 0. Interaktiver realtime Chart zur PanGenomic Health Aktie. PanGenomic Health Inc. 06208644f9027d603a46e204. PanGenomic is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. (NARA. provided an update on its NARA product and announce that it is planning to launch Conversational AI for the NARA app and web platform . 0350 (unch) PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants Newswire. PanGenomic. 1 Mindleap's aim is to. 0191. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG. Pangenomic Health will provide further updates on its application to list on the AQSE when available. 01 Nov, 2023, 17:30 ET. For more information, please contact: Jerry Lai, Investor Relations Maryam Marissen, President & CEO. is a precision health company. Juni 2023. 778 743 4642 info@chatnels. WKN. The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings. , a Santa Clara-based medical device company ("LumiQuick "). N-N6kQrkeXBQV39vtKCgMFC0uimY_VLCNyX7dlB17Y8. Pangenomic Health Inc. 22, 2022 /CNW/ - PanGenomic Health Inc. Our initial focus is on mental health. 93. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere. PressReader. VANCOUVER, BC, May 2, 2023 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce the results of its Annual. EUR. ISIN. News zur PANGENOMIC HEALTH AKTIE und aktueller Realtime-Aktienkurs PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement. PanGenomic Health Inc. , to acquire all of the issued. PanGenomic will launch the PlantGx platform in Canada and the United States in the summer 2022. 58,940. Built as an extension to its Nara consumer app and website launched in 2022, the e-commerce. PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement. com. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere mit wallstreetONLINE Pangenomic Health Registered (A) Aktie. 2. DTCFF. [email protected] Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The company has a very good potential for expansion. (“Generation IACP”) to. The Company's initial. (" PanGenomic " or the " Company ") (AQSE:NARA) (CSE:NARA), a precision health company that has developed a self-care digital platform. ("PlantGx"), has signed a development partnership. CSE: NARA, is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the “Transaction”) of Mindleap Health Inc. com Maryam Marissen, President & CEO. is a precision health company. 11. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health and wellness. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /. zXx0qinflXRXXCMJ5PxV5vqU8IKF_XlXtuCcSomJ2yTFaVWPcMmvXlBVDQPanGenomic Health Inc (NARA) Message Board - Company Name: PanGenomic Health Inc, Stock Symbol: NARA, Industry: Medical - Healthcare - Total Posts: 13 - Last Post: 05/31/2023 08:25:13 AM - company/specific stock board. Nov. CSE) on Friday announced the soft launch of thePanGenomic offers a self-care digital platform to deliver personalized, evidence-based information about natural and plant-based health treatments, according to the company. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Stocks in play: PanGenomic Health Inc Announces that further to its news release of September 1, 2022, it has entered into a definitive share. Take a look at our analysis of LL30’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately. live Aktienkurs für die beste Analyse!17. Exchange Traded Funds (ETFs): Hier finden Sie eine Übersicht über alle handelbaren ETFs, ETF Suche, ETF Vergleiche und Analysen. About PanGenomic Health. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 00: Operating Profit-0. 0 Euro pro Trade handeln (zzgl. Pangenomic Health Inc (LL30:BER) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. (“PanGenomic”) (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. com; Bello Holdings Inc. 15. 9, 2023 /CNW/ - PanGenomic Health Inc. Business Update. Automatisch Scrollen. Pangenomic Health Inc. . PanGenomic Health, Inc. Ausländisches Symbol. PanGenomic Health, Inc. View funds that move the market, screen for funds and read relevant news. Pangenomic Health Inc schüttet keine Dividende aus. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 (“LOI”) with Interactive Health Inc. PANGENOMIC HEALTH A Schätzungen: Hier finden Sie einen Überblick über die erwartete Entwicklung der wichtigsten Kennzahlen. Aktienchart mit vielen Chartindikatoren & Vergleichsmöglichkeiten inkl. The Company's initial. Novum Securities Limited, AQSE corporate Advisor. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science-backed information about natural remedy alternatives to pharmaceutical drugs. Last Funding Type Post-IPO Equity. . Media. The Company's initial focus is to support mental health. 115946 million a year ago. Artikel lesen 02. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. stock was issued. 0,0224. 11. Pangenomic Health Inc. A publicly-traded benefit corporation (CSE:NARA). This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic Health and the consideration to be paid to PanGenomic Health. marktüblicher Spreads)! Nachrichten zur PANGENOMIC HEALTH A Aktie - Aktuelle TOP-Meldungen - Die wichtigsten PANGENOMIC HEALTH A News im Überblick - seriös, schnell und kompetent. (NARA. Pangenomic Health Inc. 778 743 4642. /Not for distribution to U. As a British Columbia benefit company, the Company’s mission is to promote and improve the health and. Shares Outstanding 71. See the latest PanGenomic Health Inc stock price (XCNQ:NARA), related news, valuation, dividends and more to help you make your investing decisions. Vancouver, British Columbia, Canada Co-founder of tech centre in UBC South Research Campus (etc3. ("MUJN Diagnostics"), has launched its BDNF (brain. Pangenomic uses your genome/ proteomic profile to help users select the best plant medicine for their specific needs. CSE Index: Currency: PanGenomic Health Inc. Novum Securities Ltd. VANCOUVER, BC, Jan. Zuletzt verteuerte sich das. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. VANCOUVER, BC, Nov. 12 April 2023 at 2:00 am · 8-min read. The Company's initial. Artikel lesen 01. Nachrichten zur Aktie HP Inc (ex Hewlett-Packard) | A142VP | HPQ | US40434L1052. Ein Nutzer diskutiert die Aktie von Pangenomic Health Inc. Portfolio Tracking Watchlists Märkte Dividendenkalender Neu Community Blog Registrieren Anmelden Aktie. VANCOUVER, BC, Dec. VANCOUVER, BC, Nov. Built as an extension to its Nara consumer app and website launched in 2022, the e-commerce platform on nara. ("PanGenomic" or the "Company") (CSE: NARA) today issued a letter to shareholders from its executive team. PANGENOMIC HEALTH A AKTIE und aktueller Aktienkurs. Aktuelle Aktienempfehlungen. Pangenomic Health A Realtimekurs. caPanGenomic Health Inc. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports. 35ce8f8a3ff3a29a40d005295608833. 23, 2023 /CNW/ - PanGenomic Health Inc. | A3DN26 | CA69842E2050 | Deutsche Boerse AG. Die DWS Group (DWS) ist einer der weltweit führenden Vermögensverwalter. , has signed a development partnership agreement with LumiQuick. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. Nachrichten zur Aktie EGF Theramed Health Corp Registered Shs | A3DMEG | EVAHF. 08 Mar, 2023, 07:30 ET. operates as a precision health company. PanGenomic Health is a. 0. , has signed an agreement to lease space at Psy Integrated Health. 2. Robert Nygren. Artikel lesen 02. | PanGenomic Health’s mission is to improve the health and wellness of people by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed its audited annual financial statements for the fiscal year ended. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. Kurs Pangenomic Health Registered (A) 0,0222 EUR. MYDECINE INNOVATIONS Group Inc. ) Sartorius AG Vz. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. Die Pangenomic Health Inc Registered Shs -A- Aktie wird unter der ISIN CA69842E2050 an den Börsen Frankfurt, München, Stuttgart, Hamburg, Berlin, Gettex, Tradegate und Baader Bank gehandelt. 30. PanGenomic Health will purchase Mindleap Health for approximately $3 million. Dear Shareholders, As we. Built as an extension to its Nara consumer app and website launched in 2022, the e-commerce platform on nara. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. PanGenomic Health Inc. WKN. See the company profile for Pangenomic Health Inc. 07. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), announced today that independent directors, Peter Green and Jonathan Lutz, tendered their resignations. thyssenkrupp Materials Trading GmbH, an international raw materials trading and services company headquartered in Essen, Germany, entered into a long-term partnership and 10-year offtake agreement for the annual purchase of up to 35,000 tonnes of SuperFlake® graphite from the Molo Mine. PanGenomic Health Inc. ISIN. 9, 2021 /CNW/ - PanGenomic Health Corp. 325. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth. . (the “Issuer”). ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital. 0 out of 5. VANCOUVER, BC, July 13, 2023 /CNW/ - PanGenomic Health Inc. care will market its proprietary natural herbal remedy information. com. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Psy Integrated Health Inc. Discover historical prices for NARA. 01. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. David Coffman / George Duxberry. 0,0210. by Globe Newswire January 30, 2023. Basic loss per share from continuing operations was CAD 0. Kurs. 74%. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. euro stoxx 50. Popular. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 13: Sales - Tangible Book Value 0. PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Quotes Pangenomic Health Inc. 1,08M. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. Letzter Kurs 02. PanGenomic Health Provides Update for NARA Product and Conversational AI Canada NewsWire VANCOUVER, BC, June 6, 2023 VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. PanGenomic Health Inc. nasdaq 100. (CSE: NARA) today issued a letter to shareholders from its executive team. We believe that mental health and physical wellbeing should not be a luxury, but a basic human. Ausländisches Symbol. Sie wird über das gesamte Spektrum der Anlagedisziplinen hinweg als. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic and the. EGF THERAMED HEALTH AKTIE und aktueller Aktienkurs. Pangenomic Health Inc. (“IHI”), whereby PanGenomic Health will license IHI’s. CA69842E2050. The company was founded by Robert Nygren and Vincent Lum on December 11, 2015 and is headquartered in Vancouver, Canada. Employees. Discover historical prices for NARA. At the core of our evidence-based health platform is an. PanGenomic Health Inc. VANCOUVER, BC, Jan. 0. Nachrichten zur Aktie Cardinal Health Inc. 17, 2023 /CNW/ - PanGenomic Health Inc. 107,68. Ich möchte hier die Diskussion zur Aktie PanGenomic Health Solutions | PanGenomic eröffnen, um einen regen Austausch über die sich ergebenden Chancen zu führen. DEFENCE THERAPEUTICS A AKTIE und aktueller Aktienkurs. Zeit. VANCOUVER, BC, Jan. PanGenomic is committed to helping more people discover plant-based health remedies and giving them greater personal control over. CN : 0. ISIN. %. The Company's initial focus is to support mental health. (“Meus”) to provide capital markets advisory, investor relations and corporate strategy services. CARDINAL HEALTH AKTIE und aktueller Aktienkurs. Revenue in CAD (TTM) 0. Seien Sie informiert. 11. info@pangenomic. 12 April 2023 at 2:00 am · 8-min read. 12 April 2022. Artikel lesen 02. 13 PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. Le 15 juillet/July 2022. PanGenomic Health Inc. Empfehlungen der Analysten zur PANGENOMIC HEALTH Aktie. Primary Industries. 20 per Share. PanGenomic's. PanGenomic Health is registered under the ticker CNSX:NARA . ADRs) | 909800 | TSM | US8740391003Pangenomic Health Registered (A) Kurs heute • Aktuelle Realtime Finanzdaten, Nachrichten und Informationen zur Aktie • CA69842E2050 •Pangenomic Health Inc. The Company's initial. Change 0 % Change 0. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. In the fields of molecular biology and genetics, a pan-genome ( pangenome or supragenome) is the entire set of genes from all strains within a clade. They acquired Mindleap for CA$4M. 0500. Potential. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The Company's initial focus is to support mental health. PanGenomic Health Inc. Porsche Automobil vz. Apr. About MUJN Diagnostics. . is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence. and is focused on developing a decision support system for alternative healthcare providers. PANGENOMIC HEALTH A Bilanz - hier erhalten Sie ausführliche Bilanzinformationen zur PANGENOMIC HEALTH A Aktie. (“PanGenomic Health” or the “Company”) (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. PanGenomic Health has acquired Mindleap on Sep 1, 2022. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science. Kursentwicklung, News & Analysen. VANCOUVER, BC, Nov. PanGenomic Health Inc. jC8D5hqezC0fLUBv3ZE7v7Lap_H_jhY--LqvHti_hEw. Den Basisprospekt und die Endgültigen Bedingungen erhalten Sie hier, die Basisinformationsblätter hier. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics Inc. Pangenomic Health Inc. ISIN. *Close price adjusted for splits. Support: 888-992-3836 Home NewsWire Subscriptions. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. View the performance of global markets and browse news items by region. PanGenomic Health Inc. /NOT FOR DISTRIBUTION TO U. Die Pangenomic Health Inc Registered Shs -A- Aktie wird unter der ISIN CA69842E2050 an den Börsen Frankfurt, München, Stuttgart,. Nachrichten zur Aktie Pangenomic Health Inc Registered Shs -A- | A3DN26 |. nasdaq 100. In the last quarter PanGenomic Health, Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of. PanGenomic Health Inc. PanGenomic Health Inc. PanGenomic Health Admitted to Trading on the AQSE Growth Market in London,. is a precision health company.